Anixa Biosciences P/E Ratio

Anixa Biosciences (ANIX) currently reports a P/E ratio of -10.41. That is below the Technology sector average of 24.03. Use the charts on this page to explore Anixa Biosciences's P/E ratio history and peer comparisons.

Anixa Biosciences's P/E ratio of -10.41 is lower than the Technology sector average of 24.03. That is roughly 143.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/E ratio is a valuation multiple that relates Anixa Biosciences's market price to a fundamental measure such as earnings, sales, or book value. At -10.41, ANIX can look expensive or cheap only in context — versus its own history, growth rate, and Technology peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/E ratio of -10.41, then check the historical chart for trend and the peer comparison chart for relative positioning. The Technology average is 24.03. From there, open related valuation or income-statement pages for Anixa Biosciences, and consider following ANIX for alerts when major investors trade the stock.

Anixa Biosciences is classified in the Technology sector. On P/E ratio, it currently shows -10.41 versus a sector average near 24.03. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing ANIX with unrelated industries.